Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. - Wikidata - awgldk - TriplyDB

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.

http://www.wikidata.org/entity/Q37395599

about

Neural stem/progenitor cells in Alzheimer's disease A new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory protein Alzheimer's Disease: Mechanism and Approach to Cell Therapy Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains Rodent models of neuroinflammation for Alzheimer's disease Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system The role of inflammasome in Alzheimer's disease Targeting neuroinflammation in Alzheimer's disease Distribution and expression of CD200 in the rat respiratory system under normal and endotoxin-induced pathological conditions Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease IL-4 in the brain: a cytokine to remember.Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β.Old Maids: Aging and Its Impact on Microglia Function.Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages.Inflammation, microglia, and Alzheimer's disease.CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.Microglia activation and anti-inflammatory regulation in Alzheimer's disease Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection Combined flow cytometric analysis of surface and intracellular antigens reveals surface molecule markers of human neuropoiesis.Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex The evolving biology of microglia in Alzheimer's disease.Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.Brain biochemistry in autopsied patients with essential tremor Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells.Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia.Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases.The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease.Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Neuronal influence behind the central nervous system regulation of the immune cells.The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

P2860

Q26738352-9FA14C0B-FF81-462F-8BE7-C3782D0138A5 Q26751623-2C07968E-9695-4E61-905D-3425A053CAD0 Q26778149-A1DBB390-4079-4757-98A7-15D738F27ADF Q26796857-ED3DF6A4-EC86-4C9D-8835-CBFC3AB2EB28 Q26864804-EAE98007-AF5F-4F94-8195-B3C732380EEA Q26865295-9AE095A4-F4F2-4011-ADD0-437291B39EBB Q26996822-60C04B5D-A142-4F46-A630-3BD47EB03B3A Q28078474-F4559757-E183-40D3-BAFA-6D98880F2C60 Q28393787-C3DFDF2F-7D04-40ED-9FDE-293A8F9F247F Q28477836-3F060FCE-5917-47C1-A39B-2893DF878B86 Q28542628-3872A757-8ACD-47EE-9AC6-7D52B3EEFD9D Q30416623-D458866D-483F-442D-97F0-ED91C3E1A697 Q33359453-53B74D62-BF18-4526-BA76-7036038D31C8 Q33624540-5A2C31FA-3727-4C23-AF86-20B19FAC96D2 Q33634159-A69601F2-B1E9-4208-8079-26A4BFDBF28D Q33664099-DCA262E9-3A5B-4A0B-ACDC-2DA100C1B5BC Q33725044-0DFDC048-DD66-4B25-B7AE-5F9AC6678DB3 Q33943873-42528225-4D15-45B2-B931-9CB9BD9519DA Q34202948-841958DC-DCDF-489D-A723-C6B13063D1C7 Q34213029-05A2606F-1E24-47B2-AB81-DB5BE871E326 Q34262256-E3580EA4-95C6-41BC-B42C-03A94975FA0E Q34798025-95BB131D-E06F-404A-BCC9-98D7008C998A Q35044486-EB46F3BB-DE0E-493F-B4E3-05F043CDF748 Q35064995-E1BDCA7C-93C8-4DA9-B786-DA8FB309FA09 Q35106592-1A678363-1BCF-40E3-AC09-A1F8CBBBB4D1 Q35272389-B73B1EB3-01D9-477C-AB5D-2A3EF0D3BCEB Q35416073-9F8F4155-9B53-446E-B639-C5F0DC9398E3 Q35580088-13D0CC6E-2C7B-446B-9793-729D835F69B1 Q35590867-FF743C8D-6907-4CF8-84F6-0405FDDA77A9 Q35599843-926518FD-6BDC-4C19-A35F-4D1077E469DE Q35680914-A97E2227-0756-4A77-8CCC-8CF724E710E8 Q36121377-E8AEE122-ED5A-4A8F-ACB5-8ECACBE7F363 Q36271043-926F50A6-8BCC-4AB1-8C5B-F552DCCFDB56 Q36404125-FE72AF6B-0776-471C-AD78-039B1639BBB8 Q36445115-A48C1762-1D6A-4A25-BF7D-E26EAE49ACC9 Q36460964-4CCC4B5F-6786-4E37-B533-97EDE533DA85 Q36635842-8431816B-536B-43FE-93B4-CC75C419FB37 Q36815367-3149A318-C5A6-4CA5-8C05-A8856A0C3D61 Q37136971-F3D371B8-965D-4EFE-A977-401B05FC98A6 Q37217396-E30AC3E3-2763-4E6D-B7FE-BD22F32DFEA8

P2860

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.

http://www.wikidata.org/entity/Q37395599

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Decreased expression of CD200 ...... ading to chronic inflammation.

@en

Decreased expression of CD200 ...... ading to chronic inflammation.

@nl

type

label

Decreased expression of CD200 ...... ading to chronic inflammation.

@en

Decreased expression of CD200 ...... ading to chronic inflammation.

@nl

prefLabel

Decreased expression of CD200 ...... ading to chronic inflammation.

@en

Decreased expression of CD200 ...... ading to chronic inflammation.

@nl

P1433

Q37395599-98233D91-92FB-473D-9AE8-C6183A6BE1EF

P1476

Q37395599-B8986701-DC44-4335-8F92-734A2CEBEA6B

P2093

Q37395599-1E0B0EA0-735A-4C1C-AC61-4350943CB1E0

Q37395599-35E3348B-16D4-4640-AAFB-9EECFCC9D668

Q37395599-58DF5405-697E-43F1-A827-F6ED183379C1

Q37395599-95F3C8BA-9C4F-4910-8BEA-5B458E8F5C49

P2860

Q37395599-055D72B2-75D3-406E-B6AD-428CC3734ED5

Q37395599-10EACCB4-5657-4601-A7D9-1D5F3F0F9B85

Q37395599-13770AB9-5E8B-465E-921D-598C9A1FCA61

Q37395599-14781132-043A-4330-A2B1-7131D0F28E96

Q37395599-1C995DDB-D82C-4623-8853-0B81FA95947E

Q37395599-1D97DCAC-5F6F-48E9-81E2-2EDD72FE4972

Q37395599-202F8E81-2B9A-4817-8A83-547674A820B5

Q37395599-216BE8B8-37ED-4013-9FBF-22712FAE7F9E

Q37395599-2AB51D3A-D5DE-457F-A0EE-27E2B6D6D3AE

Q37395599-2F56AD28-9BAE-4B09-B179-E5036F18FB3C

P304

Q37395599-B7315955-9A46-4A5C-A370-3069AD6BFD35

P31

Q37395599-DE6526EE-B94B-4DA6-99C6-97D7F339E2B4

P356

Q37395599-AD6B4EC3-5AE1-46B3-AECC-DBF7BFFAAA91

P407

Q37395599-9B73EAD0-1077-4C57-A345-CCC2076FB1DC

P433

Q37395599-E4BF1050-2ED8-4ABF-A58A-D9A23EAA34C6

P478

Q37395599-D42B7E95-EB56-4950-B723-D35353FA3769

P577

Q37395599-4D32EC94-BFBD-4D21-BC32-938B257336E3

P5875

Q37395599-A81D6B30-F182-4D45-BD20-96C8D40BA70F

P698

Q37395599-F0A56223-2ECC-4FAC-8480-4F7AE2699C56

P921

Q37395599-A3642068-DC9D-4541-BEA0-0E785B57AC76

Q37395599-E9C9942E-45D4-4062-924F-7635A32FFD75

P932

Q37395599-3265AFD3-9747-484A-962A-E0F540C5DC3D

P356

J.EXPNEUROL.2008.09.003

P1433

Experimental Neurology

P1476

Decreased expression of CD200 ...... ading to chronic inflammation.

@en

P2093

Douglas G Walker

http://www.w3.org/2001/XMLSchema#string

Jessica E Dalsing-Hernandez

http://www.w3.org/2001/XMLSchema#string

Lih-Fen Lue

http://www.w3.org/2001/XMLSchema#string

Nicole A Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

Inflammation and Alzheimer's disease

PECAM-1, a key player in neuroinflammation

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging

CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.

P304

5-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2008.09.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

215

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23400392

http://www.w3.org/2001/XMLSchema#string

P698

18938162

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2765462

http://www.w3.org/2001/XMLSchema#string